Registration — KNIGHT CAPITOL CONSULTANTS for GENZYME CORPORATION (2008)

Firm

KNIGHT CAPITOL CONSULTANTS

Client

GENZYME CORPORATION

Income

—

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Follow-on biologics legislation (S. 1695, H.R. 1038, H.R. 5629) Repeal of clinical laboratory reimbursement demonstration program (H.R. 3453, S. 2099) Patent Reform (H.R. 1908, S. 1145)

Lobbyist	Covered position, as disclosed
PATRICIA KNIGHT New	Sen Hatch (1993-1998); Actg DAS for Legis, DHHS (1992),

Bills named: H.R. 1908 (110th), S. 2099 (110th), H.R. 3453 (110th), H.R. 5629 (110th), S. 1695 (110th), H.R. 1038 (110th), S. 1145 (110th)

Medicare/Medicaid MMM

Follow-on biologics legislation (S. 1695, H.R. 1038, H.R. 5629) Repeal of clinical laboratory reimbursement demonstration program (H.R. 3453, S. 2099) Patent Reform (H.R. 1908, S. 1145)

Lobbyist	Covered position, as disclosed
PATRICIA KNIGHT New	Sen Hatch (1993-1998); Actg DAS for Legis, DHHS (1992),

Bills named: H.R. 1038 (110th), S. 1695 (110th), H.R. 1908 (110th), S. 1145 (110th), H.R. 5629 (110th), S. 2099 (110th), H.R. 3453 (110th)

Medical/Disease Research/Clinical Labs MED

Follow-on biologics legislation (S. 1695, H.R. 1038, H.R. 5629) Repeal of clinical laboratory reimbursement demonstration program (H.R. 3453, S. 2099) Patent Reform (H.R. 1908, S. 1145)

Lobbyist	Covered position, as disclosed
PATRICIA KNIGHT New	Sen Hatch (1993-1998); Actg DAS for Legis, DHHS (1992),

Bills named: H.R. 1908 (110th), H.R. 1038 (110th), H.R. 3453 (110th), S. 1145 (110th), S. 2099 (110th), H.R. 5629 (110th), S. 1695 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.